Hydroxychloroquine
Showing 26 - 50 of 727
Coronavirus Infection, Coronavirus, Infectious Disease Trial in Salt Lake City (Hydroxychloroquine, Placebo oral tablet)
Active, not recruiting
- Coronavirus Infection
- +2 more
- Hydroxychloroquine
- Placebo oral tablet
-
Salt Lake City, UtahUniversity of Utah
Nov 1, 2022
NSCLC, KRAS Mutation-Related Tumors Trial in Philadelphia (Binimetinib Pill, Hydroxychloroquine Pill)
Recruiting
- Non-Small Cell Lung Cancer
- KRAS Mutation-Related Tumors
- Binimetinib Pill
- Hydroxychloroquine Pill
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Sep 30, 2022
COVID-19, Coronavirus, Coronavirus Infections Trial in Detroit (drug, other, diagnostic test)
Terminated
- COVID-19
- +3 more
- Hydroxychloroquine - Daily Dosing
- +6 more
-
Detroit, MichiganHenry Ford Hospital
Jun 15, 2022
COVID-19 Infection Trial in Strasbourg (Hydroxychloroquine, Azithromycin, Telmisartan)
Terminated
- COVID-19 Infection
- Hydroxychloroquine
- +2 more
-
Strasbourg, FranceCHU de Strasbourg
Jul 7, 2022
Prostate Cancer Trial in Darlinghurst (SUBA-itraconazole, Hydroxychloroquine)
Recruiting
- Prostate Cancer
- SUBA-itraconazole
- Hydroxychloroquine
-
Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital
May 3, 2022
Inhibition of Autophagy Synergizes Anti-tumor Effect Trial in Guangzhou (100mg bid dose of hydroxychloroquine combined with
Recruiting
- Inhibition of Autophagy Synergizes Anti-tumor Effect
- 100mg bid dose of hydroxychloroquine combined with three predefined dose groups of palbociclib
- RP2D dose of 100mg bid of hydroxychloroquine combined with palbociclib was selected for phase II clinical trial.
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 19, 2023
SARS-CoV2 (COVID 19) : Pharmacokinetic Study
Suspended
- COVID-19 Pneumonia
-
Toulouse, FranceUniversity Hospital of Toulouse
Jun 8, 2022
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Systemic Lupus Erythematosus Trial in United States (Hydroxychloroquine, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Hydroxychloroquine
- Placebo
-
Los Angeles, California
- +9 more
Mar 23, 2023
Coronavirus Infection, Pneumonia, Viral Trial in Montpellier (Hydroxychloroquine + , hydroxychloroquine + azithromycin)
Terminated
- Coronavirus Infection
- Pneumonia, Viral
- Hydroxychloroquine + placebo
- hydroxychloroquine + azithromycin
-
Montpellier, FranceMontpellier University hospital
Dec 14, 2021
Tumor, Solid, Gastrointestinal Cancer Trial in San Francisco, Ann Arbor (Ulixertinib, Hydroxychloroquine)
Recruiting
- Tumor, Solid
- Gastrointestinal Cancer
- Ulixertinib
- Hydroxychloroquine
-
Tucson, Arizona
- +7 more
Jan 13, 2023
COVID Trial in Tanta (Chloroquine or hydroxychloroquine, zinc)
Completed
- COVID
- Chloroquine or hydroxychloroquine
- zinc
-
Tanta, EgyptTanta university hospital, Assuit University, Ainshams Universit
Mar 23, 2022
Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)
Recruiting
- Sarcoma, Clear Cell
- CPI-613 + Hydroxychloroquine
-
Duarte, California
- +7 more
Nov 10, 2022
Preeclampsia Trial (Hydroxychloroquine)
Not yet recruiting
- Preeclampsia
- Hydroxychloroquine
- (no location specified)
Mar 10, 2022
COVID-19 Pandemic Trial in Bani Suwayf (Enoxaparin, Hydroxychloroquine)
Completed
- COVID-19 Pandemic
- Enoxaparin, Hydroxychloroquine
-
Banī Suwayf, Cairo, EgyptBeni-Suef University teaching Hospital
Apr 4, 2022
Primary Sjögren Syndrome Patients
Active, not recruiting
- Sjogren's Syndrome
- Parallel Assignment
-
São Paulo, Sao Paulo, Brazil
- +1 more
Nov 7, 2022
Breast Cancer Stage IIB Trial in Philadelphia (Hydroxychloroquine, Everolimus)
Recruiting
- Breast Cancer Stage IIB
- Hydroxychloroquine
- Everolimus
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 8, 2022
Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Hydroxychloroquine Pill
- Indapamide Pill
-
Calgary, Alberta, CanadaFoothills Medical Centre
May 16, 2022
Ulcerative Colitis (Disorder) Trial in Atlanta, New York (Hydroxychloroquine, Mesalamine)
Recruiting
- Ulcerative Colitis (Disorder)
- Hydroxychloroquine
- Mesalamine
-
Atlanta, Georgia
- +1 more
Sep 26, 2022
Rheumatoid Arthritis, Insufficient Response to Methotrexate or Leflunomide Trial in Strasbourg (Methotrexate + targeted therapy
Recruiting
- Rheumatoid Arthritis
- Insufficient Response to Methotrexate or Leflunomide
- Methotrexate + targeted therapy administration
- methotrexate or leflunomide + sulfasalazine + hydroxychloroquine administration
-
Strasbourg, FranceHôpitaux Universitaires de Strasbourg
Jul 8, 2022
Gastrointestinal Tumors Trial in Salt Lake City (Ulixertinib, Hydroxychloroquine)
Recruiting
- Gastrointestinal Neoplasms
- Ulixertinib
- Hydroxychloroquine
-
Salt Lake City, UtahHuntsman Cancer Institute
Mar 1, 2022
SARS-CoV Infection, Covid19 Trial in New Brunswick (Nitazoxanide, Placebo Nitazoxanide, Ribavirin)
Terminated
- SARS-CoV Infection
- Covid19
- Nitazoxanide
- +5 more
-
New Brunswick, New JerseyRobert Wood Johnson Medical School
May 3, 2022
Extra Pulmonary Sarcoidosis Trial in France (Hydroxychloroquine, Placebo)
Not yet recruiting
- Extra Pulmonary Sarcoidosis
- Hydroxychloroquine
- Placebo
-
Avignon, France
- +13 more
Apr 24, 2023
Coronavirus Infection Trial in Worldwide (Hydroxychloroquine SAR321068, Placebo)
Terminated
- Coronavirus Infection
- Hydroxychloroquine SAR321068
- Placebo
-
Boston, Massachusetts
- +6 more
Apr 21, 2022